
-
US envoys head to Mideast as Trump warns Hamas against peace deal delay
-
In-form Inter sweep past Cremonese to join Serie A leaders
-
Kolisi hopes Rugby Championship success makes South Africa 'walk tall' again
-
Ex-All Black Nonu rolls back the years again as Toulon cruise past Pau
-
Hundreds of thousands turn out at pro-Palestinian marches in Europe
-
Vollering powers to European women's road race title
-
Struggling McLaren hit bump in the road on Singapore streets
-
'We were treated like animals', deported Gaza flotilla activists say
-
Czech billionaire ex-PM's party tops parliamentary vote
-
Trump enovys head to Egypt as Hamas agrees to free hostages
-
Arsenal go top of Premier League as Man Utd ease pressure on Amorim
-
Thousands attend banned Pride march in Hungarian city Pecs
-
Consent gives Morris and Prescott another memorable Arc weekend
-
Georgian police fire tear gas as protesters try to enter presidential palace
-
Vollering powers to European road race title
-
Reinach and Marx star as Springboks beat Argentina to retain Rugby Championship
-
Russell celebrates 'amazing' Singapore pole as McLarens struggle
-
Czech billionaire ex-PM's party leads in parliamentary vote
-
South Africa edge Argentina to retain Rugby Championship
-
'Everyone's older brother': Slipper bows out in Wallabies loss
-
Thousands rally in Georgia election-day protest
-
Sinner starts Shanghai defence in style as Zverev defies toe trouble
-
Russell takes pole position for Singapore Grand Prix as McLaren struggle
-
Robertson praises All Blacks 'grit' in Australia win
-
Government, protesters reach deal to end unrest in Pakistan's Kashmir
-
Kudus fires Spurs into second with win at Leeds
-
Rival rallies in Madagascar after deadly Gen Z protests
-
Egypt opens one of Valley of the Kings' largest tombs to public
-
Ethiopia hits back at 'false' Egyptian claims over mega-dam
-
Sinner breezes past Altmaier to launch Shanghai title defence
-
Czech ex-PM set to win vote, putting Ukraine aid in doubt
-
All Blacks down Wallabies to stay in Rugby Championship title hunt
-
Gazans hail Trump ceasefire call as Hamas agrees to free hostages
-
Zverev echoes Federer over tournaments 'favouring Sinner, Alcaraz'
-
Yamal injury complicated, return date uncertain: Barca coach Flick
-
Conservative Takaichi set to be Japan's first woman PM
-
Marsh ton powers Australia to T20 series win over New Zealand
-
Verstappen lays down marker in final Singapore practice
-
French air traffic controllers cancel three-day strike
-
'A bit unusual': Russia's Sochi grapples with Ukrainian drones
-
Test skipper Gill replaces Rohit as India ODI captain
-
Israel troops still operating in Gaza after Trump, hostage family appeals
-
Jadeja stars as India crush West Indies in first Test
-
Pogacar eyes 'explosive' Euros race with Vingegaard, Evenepoel
-
Minnie Hauk, Graffard, Japan vie for Prix de l'Arc de Triomphe glory
-
Three Japanese tales of Arc heartbreak
-
Anisimova thrashes Gauff in 58 minutes to make China Open final
-
Flights resume at Munich airport after second drone scare
-
Hostage families urge immediate end to Gaza war
-
Czech ex-PM who wants to halt Ukraine aid set to win vote

Ozempic slimming craze sweeps Kosovo despite side effects
Kosovo influencer Tringa Kadriu sees the slimming drug Ozempic as a chance to shed excess pounds -- and she is not the only one in her Balkan nation, where more than half the population is overweight.
"I want to lose 15-16 kilos (33-35 pounds) in two months," Kadriu, 29, told AFP, "and then I'll continue with fitness".
Ozempic, approved in the United States to treat diabetes in 2017, has found an international market for people trying to lose weight.
Despite its cost, the drug has soared in popularity in Kosovo, a country of 1.7 million.
While Kosovo authorities have not sanctioned the drug's use for weight loss, they have noted their limited means to confront use of a drug widely available in the country.
Merita Emini-Sadiku, who heads the Kosovo university hospital's endocrinology clinic, said the cost of the drug had soared.
"The monthly dose used to be 75-80 euros ($85-91), while now it is 130-140 euros ($147-159), probably due to high demand," she said.
But she warned that "Ozempic has side effects that people are not aware of".
Ozempic use can potentially cause issues including thyroid cancer, pancreatitis, gastroparesis and bowel obstruction, according to the latest studies.
- 'Constant demand' -
Meant to treat Type 2 diabetes -- of which the WHO says Kosovo has lower than average levels -- the drug regulates blood sugar levels but also helps suppress hunger, leading to a lower calorie intake.
As a result, its potentially cancerous complications have done little to stem the drug's popularity or availability.
"I checked a lot of pharmacies in Kosovo and I noticed that Ozempic is very easy to get," said Kadriu, adding that pharmacists even suggested she gradually increase her dosage.
A worker at a pharmacy in the capital Pristina's downtown, who asked to remain anonymous, said she had trouble recalling when someone last came into her pharmacy to buy Ozempic with a diabetes prescription.
"But we have a constant demand for Ozempic without a prescription. You can guess why," she said.
Given its availability, Emini-Sadiku said authorities should exercise greater control over Ozempic's distribution.
But Bujar Vitija, a journalist specialising in health, said that would be tricky to achieve given Kosovo's poor health record-keeping.
"Unfortunately there is no data," Vitija said.
With 1,500 to 1,600 private pharmacies in Kosovo, the country's 20 pharmaceutical inspectors have their work cut out for them, he added.
- Ozempic 'every day' -
While Kosovo has lower levels of obesity than the European average, more than 57 percent of the population is overweight and 20 percent is clinically obese, according to a 2019 World Health Organization report.
And women, who are more likely to face societal pressure to be thin, were 66 percent more likely to be obese than men, the WHO report found.
But not every Kosovar who has used Ozempic had the best experience with the drug.
"I took Ozempic on the advice of a doctor for two years but it had no effect," said 48-year-old merchant Lulzim Rrahmani, adding that three of his relatives even experienced "a negative effect of the drug".
"It was just a waste of money and time."
Given the risk of side effects, Emini-Sadiku said Ozempic was "by no means to be taken without a doctor's prescription".
Yet Kadriu said she would not be deterred, adding that she saw colleagues taking the drug "every day at work".
"I don't see any symptom that would deter me."
N.Schaad--VB